Beta-blocker effects on sexual function in normal males.

Area of Science:

• Pharmacology
• Endocrinology
• Cardiovascular Medicine

Background:

• Sexual side effects are commonly reported with antihypertensives like sympatholytics and diuretics.
• Previous research relied on retrospective and self-report data, lacking objective physiological measures.

Purpose of the Study:

• To investigate the effects of four beta-blockers on sexual function using physiological, subjective, and hormonal measures.
• To compare the impact of beta-blockers with different ancillary properties on testosterone levels.

Main Methods:

• A placebo-controlled, double-blind, Latin-square study involving 30 healthy male volunteers.
• Evaluation of four beta-blockers (atenolol, metoprolol, pindolol, propranolol) and placebo over 1-week treatment periods.
• Assessment included nocturnal penile tumescence (NPT), subjective reports, and hormonal levels (testosterone, cortisol, cholesterol).

Main Results:

• All four beta-blockers significantly affected total and free testosterone levels.
• Nonselective beta-blockers (pindolol, propranolol) were associated with the most substantial testosterone reduction.
• No significant effects were observed on cortisol or cholesterol levels.
• Nocturnal penile tumescence and subjective data yielded inconclusive results, possibly due to study duration and sleep disruption.

Conclusions:

• Beta-blocker treatment, particularly with nonselective agents, can significantly reduce testosterone levels in healthy men.
• While physiological and subjective measures were inconclusive, the hormonal changes suggest a potential mechanism for beta-blocker-induced sexual dysfunction.
• Individual vulnerability to sexual dysfunction associated with specific beta-blockers, such as propranolol, may exist.